Moreover, studies have shown that inhibiting glycolysis in RA animal models reduces the inflammatory function of CD4+ T cells, the terminal differentiation of B cells, and the severity of arthritis, further indicating that the progression of RA may be glycolysis dependent to some extent (111). Here, CD4 is linked to rheumatoid arthritis.